CRISPR Therapeutics Correlations

CRSP
 Stock
  

USD 78.87  0.21  0.27%   

The correlation of CRISPR Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CRISPR Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CRISPR Therapeutics AG moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Continue to Trending Equities.
  
The ability to find closely correlated positions to CRISPR Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CRISPR Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CRISPR Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CRISPR Therapeutics AG to buy it.

Moving together with CRISPR Therapeutics

0.82ABCLAbcellera BiologicsPairCorr
0.87ABOSAcumen PharmaceuticalsPairCorr
0.88ACETAdicet BioPairCorr
0.67ACHLAchilles Therapeutics PlcPairCorr
0.75ACLXArcellxPairCorr

Moving against CRISPR Therapeutics

0.83ADAGAdagene Inc ADRPairCorr
0.81ABVCAbvc BiopharmaPairCorr
0.79ABTIAlterola BiotechPairCorr
0.79ACUSACUSPHERE INCPairCorr
0.75ACHNAchisonPairCorr
0.74ACHVAchieve Life SciencesPairCorr
0.56ACERAcer TherapeuticsPairCorr

Related Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
FUBER
AMSFT
FMSFT
AF
UBERMSFT
XOMJPM
  
High negative correlations   

CRISPR Therapeutics Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between CRISPR Therapeutics stock performing well and CRISPR Therapeutics company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze CRISPR Therapeutics' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 2.27 (0.12)  0.00 (0.06)  0.00 (0.0394)  0.00  4.00 (5.55)  17.65 
MSFT 1.64  0.04  0.03  0.10  2.02  0.0309 (1.74)  2.97 (4.10)  7.83 
UBER 3.49  0.45  0.11  0.34  3.87  0.11 (3.67)  6.40 (7.08)  21.38 
F 2.62  0.20  0.09  0.17  2.90  0.09 (2.81)  5.32 (4.03)  16.84 
T 1.11 (0.11)  0.00 (0.10)  0.00 (0.08)  0.00  2.00 (2.45)  10.60 
A 1.80  0.14  0.08  0.18  1.89  0.07 (2.03)  4.22 (3.15)  8.98 
CRM 2.46  0.11  0.06  0.13  2.83  0.05 (2.70)  5.77 (4.63)  16.84 
JPM 1.45 (0.02) (0.01)  0.05  1.52 (0.0055) (1.78)  3.03 (2.34)  10.79 
MRK 1.00  0.04  0.00  0.17  1.21 (0.0045) (1.05)  2.11 (2.50)  6.96 
XOM 1.94  0.14  0.05  0.23  2.59  0.05 (1.86)  3.33 (3.96)  10.43 

Be your own money manager

Our tools can tell you how much better you can do entering a position in CRISPR Therapeutics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run CEO Directory Now

   

CEO Directory

Screen CEOs from public companies around the world
All  Next Launch Module

CRISPR Therapeutics Corporate Directors

CRISPR Therapeutics corporate directors refer to members of a CRISPR Therapeutics board of directors. The board of directors generally takes responsibility for the CRISPR Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of CRISPR Therapeutics' board members must vote for the resolution. The CRISPR Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Simeon George - Independent DirectorProfile
Ali Behbahani - Independent DirectorProfile
Bradley Bolzon - Independent DirectorProfile
Jim Kasinger - General Counsel, Secretary to the Board of DirectorsProfile

Invested in CRISPR Therapeutics AG?

You need to understand the risk of investing before taking a position in CRISPR Therapeutics. The danger of trading CRISPR Therapeutics AG is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of CRISPR Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than CRISPR Therapeutics. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile CRISPR Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the CRISPR Therapeutics information on this page should be used as a complementary analysis to other CRISPR Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for CRISPR Stock analysis

When running CRISPR Therapeutics price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Is CRISPR Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CRISPR Therapeutics. If investors know CRISPR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CRISPR Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
B
Quarterly Revenue Growth YOY
-1.0
Return On Assets
-0.15
Return On Equity
-0.27
The market value of CRISPR Therapeutics is measured differently than its book value, which is the value of CRISPR that is recorded on the company's balance sheet. Investors also form their own opinion of CRISPR Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CRISPR Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CRISPR Therapeutics' market value can be influenced by many factors that don't directly affect CRISPR Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CRISPR Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine CRISPR Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CRISPR Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.